Navigation Links
SynteractHCR Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences

SAN DIEGO, Aug. 1, 2013 /PRNewswire/ -- SynteractHCR, a leading full-service global contract research organization (CRO), is pleased to announce Mary Clegg, senior director of clinical operations, as one of the recipients of the 2013 PharmaVOICE 100 Most Inspiring People in the Life Sciences industry. PharmaVOICE magazine releases this top 100 list annually and identifies industry thought leaders and innovators that have the biggest impact on the entire field of life sciences. Clegg is the third executive from SynteractHCR that has been recognized in the past five years.


Clegg was nominated by her peers because of her strong organizational aptitude and ability to lead and motivate with a "tirelessly positive" attitude. Her top quality management skills have been developed based on more than 20 years of experience in the industry. A registered nurse with extensive clinical trial experience in multiple therapeutic areas, Clegg has a proven ability to manage multiple projects and sites in accordance with FDA regulations. Clegg was named to the Top 100 because of her ability to influence others while being a thought leader in the industry.

"I am very pleased to see Mary recognized with this prestigious award," said Wendel Barr, SynteractHCR CEO. "Mary's selection as one of the PharmaVOICE 100 is a validation of her ability to mentor her staff and colleagues in a way that is substantial and measurable. She is inspirational as an excellent role model and most deserving of this industry recognition."

Honorees were announced in the July/August 2013 issue of PharmaVOICE magazine. Each year, PharmaVOICE receives thousands of nominations from readers who collectively nominate and vote for their choice of the most influential corporate leaders in their field. Candidates are chosen based on their ability to inspire their peers through their actions. The nominees must exhibit strong leadership qualities, fearless and unique approaches to problems, and innovation in strategies, products and services. Submissions are provided to PharmaVOICE by colleagues who believe their nominee meets all of the criteria necessary.

About SynteractHCR (

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular, and respiratory, among other indications.  For more information, please visit or follow us at @SynteractHCR.

Ryan Sabatini

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
2. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
3. Life Technologies Announces Redemption of 1.5% Convertible Senior Notes Due 2024
4. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
5. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
6. Cepheid Welcomes Senior Vice President of Human Resources
7. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
8. PinneyAssociates Announces Senior Staff Promotions
9. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
10. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
(Date:11/24/2015)... Switzerland (PRWEB) , ... November 24, 2015 , ... ... plant and the environment are paramount. Insertion points for in-line sensors can represent ... has developed the InTrac 781/784 series of retractable sensor housings , which ...
(Date:11/24/2015)... , Nov. 24, 2015 HemoShear ... on discovering drugs for metabolic disorders, announced today ... to its Board of Directors (BOD). Mr. Watkins ... of Human Genome Sciences (HGS), and also served ... Jim Powers , Chairman and CEO ...
(Date:11/23/2015)... , Nov. 24, 2015 Women with a ... CT exams face a higher risk of lung cancer than ... presented next week at the annual meeting of the Radiological ... --> --> Lung nodules ... classified as solid or subsolid based on their appearance on ...
(Date:11/23/2015)... The royalty-free a greement a llows ... 112 low- and m iddle-i ncome ... --> The Medicines Patent Pool (MPP) today announced its ... with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that ... virus.  The royalty-free licence will enable generic manufacture of daclatasvir ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
Breaking Biology News(10 mins):